1. AMRC. 2021: Our sector’s footprint. 2021. https://www.amrc.org.uk/our-sectors-footprint-in-2020. Accessed 28 Feb 2022.
2. du Plessis D, Sake JK, Halling K, et al. Patient centricity and pharmaceutical companies: is it feasible? Ther Innov Regul Sci. 2017;51(4):460–7. https://doi.org/10.1177/2168479017696268.
3. US Food and Drug Administration. FDA and European Medicines Agency Patient Engagement Cluster. 2018. https://www.fda.gov/patients/learn-about-fda-patient-engagement/fda-and-european-medicines-agency-patient-engagement-cluster. Accessed 28 Feb 2022.
4. Medicines and Healthcare products Regulatory Agency. Proposed Patient and Public Involvement Strategy 2020-25. 2021. https://www.gov.uk/government/consultations/mhra-patient-involvement-strategy-consultation/proposed-patient-and-public-involvement-strategy-2020-25 Accessed 26 Feb 2022.
5. Eberly LA, Kallan MJ, Julien HM, et al. Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open. 2020;3(12): e2031640. https://doi.org/10.1001/jamanetworkopen.2020.31640.